Search research articles
Contact Us
Filters
Showing results (141-150 of 147) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 147 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 19, 2010
Premature mortality in refractory partial epilepsy: does surgical treatment make a difference?
G S Bell, S Sinha, J de Tisi, et al.
The Journal of Infectious Diseases
|
April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines
S Zolla-Pazner, C Alving, R Belshe, et al.
The Journal of Infectious Diseases
|
July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers
T G Evans, M C Keefer, K J Weinhold, et al.
Neuroimage
|
June 24, 2010
Imaging haemodynamic changes related to seizures: comparison of EEG-based general linear model, independent component analysis of fMRI and intracranial EEG
R C Thornton, R Rodionov, H Laufs, et al.
The Journal of Infectious Diseases
|
February 1, 1996
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
J R Mascola, S W Snyder, O S Weislow, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
March 29, 2023
Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting
Alyssa G Burrows, Sophia Linton, Jenny Thiele, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
M L Clements-Mann, K Weinhold, T J Matthews, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 147) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 147 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 19, 2010
Premature mortality in refractory partial epilepsy: does surgical treatment make a difference?
G S Bell, S Sinha, J de Tisi, et al.
The Journal of Infectious Diseases
|
April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines
S Zolla-Pazner, C Alving, R Belshe, et al.
The Journal of Infectious Diseases
|
July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers
T G Evans, M C Keefer, K J Weinhold, et al.
Neuroimage
|
June 24, 2010
Imaging haemodynamic changes related to seizures: comparison of EEG-based general linear model, independent component analysis of fMRI and intracranial EEG
R C Thornton, R Rodionov, H Laufs, et al.
The Journal of Infectious Diseases
|
February 1, 1996
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
J R Mascola, S W Snyder, O S Weislow, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
March 29, 2023
Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting
Alyssa G Burrows, Sophia Linton, Jenny Thiele, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
M L Clements-Mann, K Weinhold, T J Matthews, et al.
Page
of 15